ENZ

Enzo Biochem, Inc.
ENZ

Overview Fund Activity
Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

54 hedge funds and large institutions have $43.8M invested in Enzo Biochem, Inc. in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+3
Holders Change %
+5.88%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
9
Reduced
13
Closed
3
Calls
$115K
Puts
$109K
Net Calls
+$6K
Net Calls Change
-$92K

Top Buyers

1
VCA
1
VIEX Capital Advisors
Florida
$3.18M
2
V
2
Veritable
Delaware
$206K
3
PCM
3
Potomac Capital Management
New York
$1.16M
4
VF
4
Virtu Financial
New York
$62K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$45K

Top Sellers

1
BFM
1
Boothbay Fund Management
New York
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$871K
3
AE
3
AMH Equity
New York
$0
4
EMG
4
ETF Managers Group
New Jersey
$0
5
State Street
5
State Street
Massachusetts
$384K
Name Holding Trade Value Shares
Change 		Shares
Change %
AE
51
AMH Equity
New York
– -$87K -30,000 Closed
EMG
52
ETF Managers Group
New Jersey
– -$43K -14,703 Closed
1 2
3